ArticleThe Journal of rheumatology2024

Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases.

Yumeko Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.